Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Scythian Biosciences Corp (SCYB.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 102,374
  • Shares Outstanding, K 29,334
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 4.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.33
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings -0.70 on 09/30/17
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.400 +2.65%
on 07/20/18
4.970 -29.78%
on 07/17/18
-0.310 (-8.16%)
since 06/25/18
3-Month
3.040 +14.80%
on 06/19/18
5.000 -30.20%
on 04/27/18
-1.210 (-25.74%)
since 04/25/18

Most Recent Stories

More News
Exactus Applauds Executive Chairman, Jonathan Gilbert on Launch of Impact Biosciences Corp.

Exactus Inc. (OTCQB: EXDI), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive Chairman of the Board, Jonathan Gilbert, on the launch of Impact...

SCYB.VN : 3.490 (-5.93%)
SOLCF : 1.6000 (-1.84%)
SOL.CN : 2.130 (-2.74%)
EXDI : 1.0500 (unch)
SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary

Former CEO to Take Lead in Spin Off Company

SCYB.VN : 3.490 (-5.93%)
SOLCF : 1.6000 (-1.84%)
SOL.CN : 2.130 (-2.74%)
EXDI : 1.0500 (unch)
Exactus Appoints Seasoned Industry Veteran Jonathan Gilbert As Executive Chairman of the Board

Former Scythian Biosciences Founder and CEO Assumes Newly Created Position

SCYB.VN : 3.490 (-5.93%)
APHA : 6.81 (-0.87%)
EXDI : 1.0500 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 3.883
1st Resistance Point 3.687
Last Price 3.490
1st Support Level 3.377
2nd Support Level 3.263

See More

52-Week High 8.613
Fibonacci 61.8% 5.709
Fibonacci 50% 4.813
Fibonacci 38.2% 3.916
Last Price 3.490
52-Week Low 1.013

See More

Business Summary

Scythian Biosciences Corp is a pre-clinical research and development company. It is engaged in the process of development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar